Sanofi, Boehringer agree to swap assets | Chemical & Engineering News
Volume 94 Issue 27 | p. 15 | Concentrates
Issue Date: July 4, 2016

Sanofi, Boehringer agree to swap assets

Department: Business
Keywords: pharmaceuticals, mergers & acquisitions, consumer health, animal health

After six months of negotiations, Sanofi and Boehringer Ingelheim have finalized a $25 billion deal to exchange Merial, Sanofi’s animal health unit, for Boehringer’s consumer health care business. Merial is being valued at $12.6 billion and the consumer health business at $7.4 billion. To make up the difference, Boehringer will pay Sanofi $5.2 billion in cash. Pending regulatory approvals, the swap is to be completed by the end of the year. Boehringer’s animal health business will more than double in size to an estimated $4.2 billion in annual sales. Sanofi’s consumer health sales should hit $5.4 billion.

Chemical & Engineering News
ISSN 0009-2347
Copyright © American Chemical Society

Leave A Comment

*Required to comment